Who knows anymore nano ?
Here's a section from a March 20, 2006 PR.
The Company is currently developing drugs against avian flu (H5N1), emerging highly pathogenic avian influenza threats (HPAI such as H9N2), common influenza, and rabies. The Company plans to develop additional drugs against HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. and Hepatitis C in the near future. "Our goal is to file two INDAs with the FDA within the next 12-18 months," said Dr. Seymour.
----------------------------------------------------------------
"File two INDA's with the FDA within the next 12-18 months".
Now that would have been 2007 - right?
Isn't it now 2010 ? And there is yet to be a Tox package started?
Also isn't the time limit up on MTA terms with Mystery pharma?
Just asking some questions here folks.
Some straight unemotional answers will be gladly appreciated.
-Bunny-
Market Data 
Markets 
AI
